Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
152 Avinguda de la Generalitat , Sant Cugat del Vallès, CT, 08174, ES
Grifols Partnership is a CDMO focused on added value injectable products, with a large international experience in the development and manufacturing of sterile drug products (small molecules) in glass vials and PP bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the U.S. FDA, EU and U.S. GMP and authorization for parametric release sterility.
Expands global API manufacturing capacity.
By: Charlie Sternberg
Site provides process R&D, analytical and stability testing, cGMP API manufacturing, and CMC support.
By: Kristin Brooks
The investment will support the upgrade and retrofit of the existing facility and enhance Novo Nordisk’s capacity to manufacture oral GLP-1s.
Bora acquired a Mississauga, Ontario facility from GSK in 2020.
By: Patrick Lavery
Announces a $380 billion investment to support the production of AbbVie's next-gen neuroscience and obesity medications.
Enhances its ability to serve regulated European markets while adhering to globally benchmarked quality and compliance standards.
Will support more than 500 skilled biomanufacturing jobs when fully operational and more than 4,000 construction jobs during site development.
Will create 300 jobs across engineering, production, automation, quality, and mold maintenance.
Garijo’s priority will be to strengthen the productivity, governance, and innovation capacity of Research & Development.
Fong most recently served in the same capacity for BioCryst Pharmaceuticals.
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo.
Faoro most recently served in the same chief medical officer capacity at Quanta Therapeutics.
The site will be the company’s latest injectable medicine and device manufacturing facility.
Construction is scheduled to begin in the second quarter of 2026.
Adds Noramco commercial manufacturing site in Wilmington, DE and Purisys clinical API manufacturing facility in Athens, GA.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
